Glyburide
Product Images NDC 66116-360

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 66116-360). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure For Glyburide (A53e29b3 7436 419f Ad6c 0a805d97ab1a 01)

Chemical structure diagram of the active ingredient glyburide, showing its molecular composition and arrangement including chloro, methoxy, sulfonyl, and urea functional groups.*

FDA Label Image

Glyburide 5mg Tablets (A53e29b3 7436 419f Ad6c 0a805d97ab1a 02)

Label for Glyburide Tablets USP 5 mg by MedVantx, Inc. The package contains 60 tablets. The label includes directions to see package insert for dosage, with blank spaces for tablet count, frequency, and duration. It shows storage information at controlled room temperature (20-25°C, 68-77°F), and indicates the product is Rx only, sample only, and not for sale. Manufacturer is listed as Novopharm Limited, Toronto, Canada, with distribution by MedVantx, Inc., San Diego, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.